Humankind Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Sell |
3,039
-458
| -13% | -$57.5K | 0.09% | 92 |
|
|
2025
Q1 | $479K | Buy |
3,497
+487
| +16% | +$66.6K | 0.12% | 88 |
|
|
2024
Q4 | $460K | Buy |
3,010
+739
| +33% | +$113K | 0.12% | 90 |
|
|
2024
Q3 | $440K | Buy |
2,271
+367
| +19% | +$71.1K | 0.16% | 86 |
|
|
2024
Q2 | $441K | Sell |
1,904
-283
| -13% | -$65.6K | 0.12% | 87 |
|
|
2024
Q1 | $472K | Buy |
2,187
+247
| +13% | +$53.3K | 0.12% | 83 |
|
|
2023
Q4 | $502K | Buy |
1,940
+346
| +22% | +$89.5K | 0.15% | 71 |
|
|
2023
Q3 | $410K | Buy |
1,594
+231
| +17% | +$59.4K | 0.17% | 72 |
|
|
2023
Q2 | $388K | Sell |
1,363
-844
| -38% | -$240K | 0.15% | 77 |
|
|
2023
Q1 | $614K | Buy |
2,207
+186
| +9% | +$51.7K | 0.25% | 61 |
|
|
2022
Q4 | $560K | Sell |
2,021
-828
| -29% | -$229K | 0.24% | 62 |
|
|
2022
Q3 | $761K | Buy |
2,849
+282
| +11% | +$75.3K | 0.37% | 42 |
|
|
2022
Q2 | $524K | Buy |
2,567
+36
| +1% | +$7.35K | 0.25% | 60 |
|
|
2022
Q1 | $533K | Buy |
2,531
+556
| +28% | +$117K | 0.22% | 59 |
|
|
2021
Q4 | $474K | Buy |
1,975
+637
| +48% | +$153K | 0.6% | 56 |
|
|
2021
Q3 | $379K | Buy |
1,338
+72
| +6% | +$20.4K | 0.58% | 60 |
|
|
2021
Q2 | $438K | Buy |
1,266
+425
| +51% | +$147K | 0.78% | 42 |
|
|
2021
Q1 | $235K | Buy |
+841
| New | +$235K | 0.72% | 53 |
|